| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 195,826 | 203,805 | 198,844 | 243,555 | | Cost of Revenue | (61,570) | 15,752 | 20,664 | 25,154 | | | Gross Profit | 257,396 | 188,053 | 178,180 | 218,401 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 216,885 | 143,362 | 150,355 | 164,433 | | Non Recurring | 1,381 | 29,665 | 147,088 | 67,819 | | Others | 19,048 | 19,652 | 20,500 | 20,399 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,251 | (4,626) | (139,763) | (34,250) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 53,099 | (30,534) | (57,545) | 1,271 | | Earnings Before Interest And Taxes | 74,051 | (34,322) | (193,896) | (32,979) | | Interest Expense | 75,425 |
-
| (20,008) | 20,008 | | Income Before Tax | (1,374) | (34,322) | (173,888) | (52,987) | | Income Tax Expense | (3,156) | (9,830) | (63,999) | (5,524) | | Minority Interest | (27) | (20) | 38 | (170) | | | | Net Income From Continuing Ops | 1,755 | (24,512) | (109,851) | (47,633) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (5) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,755 | (24,512) | (109,851) | (47,638) | | Preferred Stock And Other Adjustments | (10,466) | 10,466 | 58,094 | (1,039) | | | Net Income Applicable To Common Shares | ($8,711) | ($14,046) | ($51,757) | ($48,677) |
|
0.14% Nasdaq 
Income Statement
